Your browser doesn't support javascript.
loading
CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression.
Wu, Jieheng; Liu, Xinlei; Wu, Jiangwei; Lou, Chunju; Zhang, Qiaoling; Chen, Huiping; Yang, Zeyang; Long, Shiqi; Wang, Yun; Shang, Zhenling; Hu, Zuquan; Zhang, Rui; Zhang, Jian; Zeng, Zhu.
Afiliação
  • Wu J; Department of Immunology, Guizhou Medical University, 550025 Guiyang, China; Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Province, School of Biology and Engineering/School of Basic Medical Sciences
  • Liu X; Guizhou Prenatal Diagnsis Center, The Affiliated Hospital of Guizhou Medical University, 550001 Guiyang, China.
  • Wu J; Department of Immunology, Guizhou Medical University, 550025 Guiyang, China.
  • Lou C; Department of Immunology, Guizhou Medical University, 550025 Guiyang, China.
  • Zhang Q; Department of Immunology, Guizhou Medical University, 550025 Guiyang, China.
  • Chen H; Department of Immunology, Guizhou Medical University, 550025 Guiyang, China.
  • Yang Z; Department of Immunology, Guizhou Medical University, 550025 Guiyang, China.
  • Long S; Department of Immunology, Guizhou Medical University, 550025 Guiyang, China; Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Province, School of Biology and Engineering/School of Basic Medical Sciences
  • Wang Y; Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Province, School of Biology and Engineering/School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China; Immune Cells and Antibod
  • Shang Z; Department of Immunology, Guizhou Medical University, 550025 Guiyang, China.
  • Hu Z; Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Province, School of Biology and Engineering/School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China; Immune Cells and Antibod
  • Zhang R; Department of Immunology, Guizhou Medical University, 550025 Guiyang, China; Department of Immunology, The Fourth Military Medical University, Xi'an 710032, China.
  • Zhang J; Department of Thoracic Surgery, The Affiliated Hospital of Guizhou Medical University, 550001 Guiyang, China. Electronic address: 13985114120@163.com.
  • Zeng Z; Department of Immunology, Guizhou Medical University, 550025 Guiyang, China; Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Province, School of Biology and Engineering/School of Basic Medical Sciences
Biochim Biophys Acta Mol Basis Dis ; 1868(11): 166521, 2022 11 01.
Article em En | MEDLINE | ID: mdl-35985448
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Fibroblastos Associados a Câncer / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Biochim Biophys Acta Mol Basis Dis Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Fibroblastos Associados a Câncer / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Biochim Biophys Acta Mol Basis Dis Ano de publicação: 2022 Tipo de documento: Article